🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
21.01
+0.36 (1.74%)
At close: Nov 18, 2026, 4:00 PM EST
21.49
+0.48 (2.28%)
After-hours: Nov 18, 2026, 7:45 PM EST

Beam Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-108.35-79.99-376.74-132.53-289.09-370.64
Depreciation & Amortization
22.1322.2921.9320.0114.157.45
Asset Writedown & Restructuring Costs
-14.51---154.95
Loss (Gain) From Sale of Investments
-263.07-274.65-8.67-11.15-29.61-17.77
Loss (Gain) on Equity Investments
----25.5-
Stock-Based Compensation
77.3394.24120.6698.6584.3243.57
Other Operating Activities
11.729.515.8-7.72-34.374.91
Change in Accounts Receivable
----300-300
Change in Accounts Payable
7.096.041.81-7.582.370.82
Change in Unearned Revenue
-120.48-135.42-36.52-159.56-35.92348.16
Change in Other Net Operating Assets
-15.25-1.64-75.5150.68-14.8362.28
Operating Cash Flow
-388.65-345.1-347.25-149.222.53-66.27
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.59-14.95-8.95-33.73-48.95-46.81
Cash Acquisitions
--0.08---0.62
Investment in Securities
235.25-106.41193.95105.57-412.39-247.95
Investing Cash Flow
225.66-121.44185.0171.84-461.34-294.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
---0.49-2.25-2.29-2.12
Net Debt Issued (Repaid)
93.89--0.49-2.25-2.29-2.12
Issuance of Common Stock
15.27478.058.22278.7114.07767.08
Other Financing Activities
-0.81----0.19-8.82
Financing Cash Flow
108.34478.057.74276.45111.59756.14

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-54.6411.51-154.5199.09-327.22395.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-398.24-360.05-356.19-182.93-26.42-113.08
Free Cash Flow Growth
------
Free Cash Flow Margin
-271.57%-257.65%-560.77%-48.43%-43.38%-218.11%
Free Cash Flow Per Share
-3.84-3.64-4.33-2.37-0.38-1.76
Levered Free Cash Flow
-262.63-220.31-156.52-50.36138.32-335.34
Unlevered Free Cash Flow
-258.84-220.31-156.52-50.36138.32-335.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.16-0.030.160.380.57
Change in Working Capital
-128.64-131.02-110.22-116.46251.63111.25
SEC Filings: 10-K · 10-Q